Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-25-016223

Options or other derivatives

  • CEO acquired 0 shares (option exercise)
  • CEO acquired 66,052 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pershing Edward CEO 2025-09-30 Option exercise · 8% Unsecured Convertible Promissory Note −0 D: show line 1 in the form
Pershing Edward CEO 2025-09-30 Option exercise · Series D-1 Convertible Preferred Stock +66,052 2,484,499 D: show line 2 in the form
Loading xslF345X05/ownership.xml…